| Literature DB >> 33435405 |
Gina Gheorghe1,2, Madalina Ilie1,2, Simona Bungau3, Anca Mihaela Pantea Stoian4, Nicolae Bacalbasa5, Camelia Cristina Diaconu6,7.
Abstract
Nowadays, humanity faces one of the most serious health crises, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The severity of coronavirus disease 2019 (COVID-19) pandemic is related to the high rate of interhuman transmission of the virus, variability of clinical presentation, and the absence of specific therapeutic methods. COVID-19 can manifest with non-specific symptoms and signs, especially among the elderly. In some cases, the clinical manifestations of hyponatremia may be the first to appear. The pathophysiological mechanisms of hyponatremia among patients with COVID-19 are diverse, including syndrome of inappropriate antidiuretic hormone secretion (SIADH), digestive loss of sodium ions, reduced sodium ion intake or use of diuretic therapy. Hyponatremia may also be considered a negative prognostic factor in patients diagnosed with COVID-19. We need further studies to evaluate the etiology and therapeutic management of hyponatremia in patients with COVID-19.Entities:
Keywords: COVID-19; SARS-CoV-2; SIADH; dyselectrolytemia; hyponatremia
Mesh:
Substances:
Year: 2021 PMID: 33435405 PMCID: PMC7827825 DOI: 10.3390/medicina57010055
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430